X-ZELL Blog Episode 10

Episode 10 Think macro, act micro Less than two years after starting the transition from local research company into global enterprise, X-ZELL is about to celebrate our biggest milestone yet – the long-anticipated world premiere of the X-ZELL Cryoimmunostaining™...

X-ZELL welcomes new Brand Ambassadors

X-ZELL welcomes new Brand Ambassadors Singapore, February 2019 – In a move to support the forthcoming world premiere of the X-ZELL Cryoimmunostaining™ Suite, X-ZELL is proud to announce the appointment of Heinz Hildebrand and Troy Bailey as the company’s new Brand...

X-ZELL Blog Episode 9

Episode 9 Why prostate cancer screening is back on the agenda Largely unnoticed by the general public, early prostate cancer detection recently rose to the very top of the European Parliament’s teeming agenda. Coinciding with the European Prostate Cancer Awareness Day...

Global launch of X-ZELL Cryoimmunostaining™ Suite confirmed

Global launch of X-ZELL Cryoimmunostaining™ Suite confirmed Singapore, February 2019 – Rare cell detection specialist X-ZELL has officially confirmed the launch of the world’s first 9-colour immunostaining system. Originally designed to enable the company’s...

X-ZELL signs research collaboration agreement with DxD Hub

X-ZELL signs research collaboration agreement with Diagnostics Development Hub X-ZELL is now officially partnering with Singapore’s DxD Hub.   Singapore, December 2018 – In a move that will accelerate the company’s capabilities and scale up its...